| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |